Table 2 Characteristics of study participants reporting antibiotic use in the ten days prior to enrolment by syndrome

Last dose of reported antibiotic°

 Same day

3,860

53.2%

1,188

54.0%

880

53.6%

1,619

53.8%

173

42.3%

 1–2 days ago

3,097

42.7%

916

41.7%

697

42.4%

1,272

42.3%

212

51.8%

 3–10 days ago

301

4.1%

94

4.3%

65

4.0%

118

3.9%

24

5.9%

Symptom onset*

N = 7,170

N = 2,191

N = 1,569

N = 3,007

N = 403

 0–3 days ago

2,763

38.5%

881

40.2%

757

48.2%

996

33.1%

129

32.0%

 4–7 days ago

3,276

45.7%

942

43.0%

681

43.4%

1,421

47.3%

232

57.6%

 8–10 days ago

1,131

15.8%

368

16.8%

131

8.3%

590

19.6%

42

10.4%

Sex and age*

N = 7,140

N = 2,142

N = 1,624

N = 2,970

N = 404

 Male, < 5 years

2,286

32.0%

524

24.5%

673

41.4%

882

29.7%

207

51.2%

 Female, < 5 years

1,784

25.0%

407

19.0%

495

30.5%

733

24.7%

149

36.9%

 Male, ≥ 5 years

1,578

22.1%

642

30.0%

192

11.8%

728

24.5%

16

4.0%

 Female, ≥ 5 years

1,492

20.9%

569

26.6%

264

16.3%

627

21.1%

32

7.9%

Weight category¥

N = 5,325

N = 1,600

N = 1,100

N = 2,364

N = 261

 Underweight

1,749

32.8%

401

25.1%

514

46.7%

698

29.5%

136

52.1%

 Normal

2,676

50.3%

919

57.4%

420

38.2%

1,240

52.5%

97

37.2%

 Overweight

569

10.7%

185

11.6%

99

9.0%

264

11.2%

21

8.0%

 Obese

331

6.2%

95

5.9%

67

6.1%

162

6.9%

7

2.7%

Co-morbidities*

N = 7,181

N = 2,184

N = 1,627

N = 2,964

N = 406

 No

6,612

92.1%

2,017

92.4%

1,546

95.0%

2,676

90.3%

373

91.9%

 Yes

569

7.9%

167

7.6%

81

5.0%

288

9.7%

33

8.1%

Antimalarials*

N = 7,036

N = 2,154

N = 1,600

N = 2,884

N = 398

 No

5,631

80.0%

1,684

78.2%

1,233

77.1%

2,423

84.0%

291

73.1%

 Yes

1,405

20.0%

470

21.8%

367

22.9%

461

16.0%

107

26.9%

Other medication*

N = 6,992

N = 2,144

N = 1,581

N = 2,872

N = 395

 No

3,391

48.5%

1,029

48.0%

713

45.1%

1,506

52.4%

143

36.2%

 Yes

3,601

51.5%

1,115

52.0%

868

54.9%

1,366

47.6%

252

63.8%